Search for: "Holman"
Results 401 - 420
of 804
Sorted by Relevance
|
Sort by Date
11 Nov 2022, 9:40 am
Holman, Is the Chemical Genus Claim Really “Dead” at the Federal Circuit? [read post]
23 May 2023, 2:37 pm
By Chris Holman Much has been already been written about the Supreme Court’s recent decision in Amgen v. [read post]
4 Oct 2022, 11:47 am
by Chris Holman Mylan Pharms. [read post]
24 Dec 2022, 8:45 am
by Chris Holman A branded drug manufacturer can sometimes extend its exclusive right to market a drug by patenting a method of using the drug and successfully suing a potential generic competitor for infringement based on the premise that an instruction or warning appearing on the generic product’s label will induce doctors and/or patients to infringe the patent. [read post]
11 Dec 2023, 7:43 am
By Chris Holman Sections 271(b) and 271(c) of the Patent Act form the statutory basis for the two forms of indirect patent infringement, induced and contributory, respectively. [read post]
9 Aug 2022, 5:53 pm
We already have several posts on the case in Patently-O: Dennis Crouch, The Sound of Silence and the Inherency Doctrine for Written Description, Patently-O (July 29, 2022) Chris Holman, Federal Circuit Flips “Negative Claim Limitation” Decision after Change in Panel Composition, Patently-O (June 23, 2022) Two groups of law professors have each filed an amicus brief in support of the petition. [read post]
23 Jun 2010, 2:45 am
Liz Holman gave the CBI view, rather uninspiring. [read post]
14 Sep 2011, 12:10 am
(Holman’s Biotech IP Blog) US: Classen v. [read post]
23 Nov 2021, 9:35 am
Holman. [read post]
26 Aug 2009, 6:12 am
The Corporate Gold Rush to Patent Your Genes’ perpetuates popular misperceptions surrounding gene patents (Holman's Biotech IP Blog) Australian pharmaceutical patent term extension for patches and implants: N V Organon; LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limited (Patent Baristas) China: Obama Administration and compulsory licensing in China (China Hearsay) China: Forty-two of Simcere’s generic drugs enter China’s Essential Drug List… [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning… [read post]
13 May 2013, 11:35 am
The Court of Appeals distinguished this case factually from the Kentucky Supreme Court’s decision in Holman v. [read post]
15 Jun 2023, 2:20 pm
By Chris Holman In re Couvaras, 2023 WL 3984753 (Fed. [read post]
6 Jan 2009, 4:40 am
In addition, Chris cofounded the IPBiotech listserv, and then founded Holman's Biotech IP Blog (http://holmansbiotechipblog.blogspot.com/). [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
19 Jul 2021, 1:36 pm
Holman, an inspiring advocate for her brother, told the Commercial Appeal. [read post]
16 Jul 2012, 9:53 am
“Public Citizen will continue demanding action until Congress finally lifts the veil of secrecy from money in politics,” Holman said. [read post]
7 Dec 2007, 4:18 am
Arthur came within hours of lethal injection at Holman prison on Sept. 27, when Gov. [read post]
15 Jul 2008, 4:00 am
Holman, __ F.3d _ (4th Cir. [read post]
15 Jul 2008, 4:00 am
Holman, __ F.3d _ (4th Cir. [read post]
